Results 151 to 160 of about 207,759 (231)

Advancing Biochemical Molecule Registration, Representation and Search for New Drug Modalities. [PDF]

J Chem Inf Model
Pinto-Gil K, De Maria L, Noisier AFM, Leung S, Garon A, Frolov A, Chankeshwara SV, Bood M, Brive L, Tomkinson NP, Alvarez-Garcia D, Broddefalk J, Chooi KP, Ingar A, Bolt H, Ghiandoni GM.   +15 more
europepmc   +1 more source

Multi-Center Prototype Feature Distribution Reconstruction for Class-Incremental SAR Target Recognition. [PDF]

Sensors (Basel)
Zhang K, Wu B, Li P, Kang Z, Zhang L.
europepmc   +1 more source

Classification of hepatocellular carcinoma Ki-67 expression status by a simple combination of magnetic resonance slow diffusion coefficient (SDC) and apparent diffusion coefficient (ADC): initial promising results. [PDF]

Quant Imaging Med Surg
Yang NJ, Zeng WT, Xiang HY, Wáng YXJ.
europepmc   +1 more source

An Event based Body Coupled Transdural Telemetry for Intracortical Brain Computer Interfaces. [PDF]

Commun Eng
Shi C, Nuttin L, Gao Z, He Y, Russo P, Liaw HP, Gourdouparis M, Lambrechts D, Dolmans G, Liu YH.   +9 more
europepmc   +1 more source

A 1.5-GS/s 12-bit 58.9-dB SNDR Pipelined ADC with Weight-Regulated Dither-Based Interstage Gain Error Calibration. [PDF]

Sensors (Basel)
Xu S, Zhang Z, Zhang D, Wu G, Zhan L.
europepmc   +1 more source

Antibody-drug conjugate engineering: from design to efficacy and safety. [PDF]

Signal Transduct Target Ther
Ocana A, Espinosa JR, Alonso-Moreno C, Győrffy B, Tong H, Pandiella A.   +5 more
europepmc   +1 more source

Case Report: Dramatic response of trastuzumab rezetecan in an NSCLC patient with EGFR sensitive mutation and primary ERBB2 genetic alterations. [PDF]

Front Oncol
Zhang L, Zhang C, Wang H, Li Q, Wang Y, Huang X, Sun D, Hou H, Zhang L.   +8 more
europepmc   +1 more source

Improvement of magnetic resonance imaging diffusion metric 'slow diffusion coefficient (SDC)' over apparent diffusion coefficient (ADC) for isocitrate dehydrogenase (IDH) genotyping in diffuse gliomas. [PDF]

Quant Imaging Med Surg
Zheng WY, Shi YT, He YY, Lin RL, Xiao BH, Jiang RF, Wáng YXJ.   +6 more
europepmc   +1 more source

The current landscape of bladder-sparing therapies in BCG-refractory high-risk nonmuscle-invasive bladder cancer. [PDF]

Curr Urol
Gu Y, He W, Yu X, Jiang C, Zhang Z, Xu C, Zeng S.   +6 more
europepmc   +1 more source

Organic Cosolvent-Free Antibody-Drug Conjugation Enabled by Hydrophilic Linker-Payloads. [PDF]

ACS Omega
Matsuda Y, Cheng H, Hartung J, Schwartz I, Li H, Chang JR, Watson SS, Mahajan R, Mendelsohn BA, Martinelli MJ.   +9 more
europepmc   +1 more source